Advanced Proteomics for Drug Discovery and Biotherapeutics
Curriculum focus: MS technologies critical for identifying and characterizing drug targets, antigens, and biotherapeutic.
Date: Sept 22-26, 2025
Location: Science Park, Utrecht, NL
Overview:
This week-long course provides an in-depth exploration of the latest mass spectrometry (MS) technologies used to identify and characterize drug targets, antigens, and biotherapeutics. Designed for PhD-level students familiar with MS, this course offers comprehensive training in immuno-oncology proteomics, glycoproteomics, antibody sequencing, and cutting-edge techniques for analyzing intact biotherapeutics. Participants will gain the expertise to tackle analytical challenges in biomarker identification, protein analysis, and biotherapeutic characterization, preparing them for advanced roles in drug discovery and biopharmaceutical research.
Why Take This Course?
This is your chance to gain an in-depth, hands-on understanding of the most advanced mass spectrometry tools used in the drug discovery pipeline. Ideal for those looking to deepen their expertise in proteomic technologies applied to biopharmaceutical sciences —take your research to the next level with cutting-edge knowledge of proteomics in therapeutic development!
Instructors:
- Prof. Albert Heck
- Dr. Joost Snijder
- Dr. Kelly Stecker
- Dr. Karli Reiding
- Dr. Marc Baggelaar
- Dr. Kelly Stecker
- Dr. Jean-Francois Greisch
- Dr. Stewart Hamish
Topics overview:
- Immunopeptidomics
- Glyoproteomics
- De novo sequecing
- Antibody profiling
- Native MS
- Charge Detection MS
- Surface antigen discovery
- MS instrumentation
- Fragmentation
